2nd Apr 2007 07:00
2 April 2007
Shire plc ("Shire")
Purchase of Shares by Employee Benefit Trust
Shire has today been notified by Towers Perrin Share Plan Services (Guernsey) Ltd (the "Trustee") as trustee of Shire plc Employee Benefit Trust (the "Trust") that it will commence an irrevocable, non-discretionary programme to purchase Ordinary Shares of Shire plc ("Shares") and American Depositary Receipts of Shire plc ("ADR's") for the benefit of the Trust during the period commencing on 02 April 2007 and ending on 30 April 2007. Any purchases will be conducted within certain pre-set parameters agreed between the Trust and an independent third party broker.
For further information please contact:
Investor Relations Clĩa Rosenfeld (Rest of the World) +44 1256 894 160 Eric Rojas (North America) +1 484 595 8252 Notes to editorsSHIRE PLC
Shire's strategic goal is to become the leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.
Shire's focused strategy is to develop and market products for specialty physicians. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.
For further information on Shire, please visit the Company's website: www.shire.com.
Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Press Release
Registered in England 5492592Registered Office as above
SHIRE PLCRelated Shares:
Shire